1.Fontana G, See E, Pandit A. Current trends in biologics delivery to restore intervertebral disc anabolism. Adv Drug Deliv Rev. 2015;84:146–58.
2.Pattappa G, Li Z, Peroglio M, Wismer N, Alini M, Grad S. Diversity of intervertebral disc cells: phenotype and function. J Anat. 2012;221(6):480–96.
3.Arkesteijn ITM, Potier E, Ito K. The Regenerative Potential of Notochordal Cells in a Nucleus Pulposus Explant. Global Spine J. 2017;7(1):14–20.
4.Wang X, Wang B, Zou M, Li J, Lu G, Zhang Q, et al. CircSEMA4B targets miR–431 modulating IL–1beta-induced degradative changes in nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway. Biochim Biophys Acta, Mol Basis Dis. 2018;1864(11):3754–68.
5.Cheng X, Zhang G, Zhang L, Hu Y, Zhang K, Sun X, et al. Mesenchymal stem cells deliver exogenous miR–21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med. 2018;22(1):261–76.
6.Ding F, Shao ZW, Xiong LM. Cell death in intervertebral disc degeneration. Apoptosis. 2013;18(7):777–85.
7.Martirosyan NL, Patel AA, Carotenuto A, Kalani MY, Belykh E, Walker CT, et al. Genetic Alterations in Intervertebral Disc Disease. Front Surg. 2016;3:59.
8.Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155.
9.Yu Y, Zhang X, Li Z, Kong L, Huang Y. LncRNA HOTAIR suppresses TNF-α induced apoptosis of nucleus pulposus cells by regulating miR–34a/Bcl–2 axis. Biomed Pharmacother. 2018;107:729–37.
10.Guo C, Wang X, Chen L, Li M, Li M, Hu Y, et al. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(12):3703–12.
11.Zhou H-J, Wang L-Q, Wang D-B, Yu J-B, Zhu Y, Xu Q-S, et al. Long noncoding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via the modulation of a miR–199b/IKKβ/NF-κB signaling pathway. American Journal of Physiology-Cell Physiology. 2018;315(1):C52-C61.
12.Yan W, Wu Q, Yao W, Li Y, Liu Y, Yuan J, et al. MiR–503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1. Sci Rep. 2017;7(1):11313.
13.Li Q, Li C, Xi S, Li X, Ding L, Li M. The effects of photobiomodulation therapy on mouse pre-osteoblast cell line MC3T3-E1 proliferation and apoptosis via miR–503/Wnt3a pathway. Lasers Med Sci. 2019;34(3):607–14.
14.Wang J, Hu J, Chen X, Huang C, Lin J, Shao Z, et al. BRD4 inhibition regulates MAPK, NF-κB signals, and autophagy to suppress MMP–13 expression in diabetic intervertebral disc degeneration. The FASEB Journal. 2019;33(10):11555–66.
15.Li J-k, Nie L, Zhao Y-p, Zhang Y-q, Wang X, Wang S-s, et al. IL–17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP–1-dependent manner in human nucleus pulposus cells. J Transl Med. 2016;14(1):77.
16.Studer RK, Aboka AM, Gilbertson LG, Georgescu H, Sowa G, Vo N, et al. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration. Spine. 2007;32(25):2827–33.
17.Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine. 2000;25(23):3005–13.
18.Wuertz K, Vo N, Kletsas D, Boos N. Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-KB and MAP kinases. Eur Cell Mater. 2012;23:103–19.
19.Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin–1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005;7(4):R732–45.
20.Le Maitre CL, Hoyland JA, Freemont AJ. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL–1β and TNFα expression profile. Arthritis Res Ther. 2007;9(4):R77.
21.Yamamoto J, Maeno K, Takada T, Kakutani K, Yurube T, Zhang Z, et al. Fas ligand plays an important role for the production of pro‐inflammatory cytokines in intervertebral disc nucleus pulposus cells. J Orthop Res. 2013;31(4):608–15.
22.Rand N, Reichert F, Floman Y, Rotshenker S. Murine nucleus pulposus-derived cells secrete interleukins–1-β,–6, and–10 and granulocyte-macrophage colony-stimulating factor in cell culture. Spine. 1997;22(22):2598–601.
23.Kepler CK, Markova DZ, Hilibrand AS, Vaccaro AR, Risbud MV, Albert TJ, et al. Substance P stimulates production of inflammatory cytokines in human disc cells. Spine. 2013;38(21):E1291-E9.
24.Zhang H, Li J, Duan D, She W, Wang L, Zhang F. The role of lncRNA MALAT1 in intervertebral degenerative disc disease. Int J Clin Exp Pathol. 2017;10(10):10611–7.
25.Liu Z, Ma C, Shen J, Wang D, Hao J, Hu Z. SDF‑1/CXCR4 axis induces apoptosis of human degenerative nucleus pulposus cells via the NF‑κB pathway. Molecular medicine reports. 2016;14(1):783–9.
26.Wang Y-J, Shi Q, Lu WW, Cheung KC, Darowish M, Li T-F, et al. Cervical intervertebral disc degeneration induced by unbalanced dynamic and static forces: a novel in vivo rat model. Spine. 2006;31(14):1532–8.
27.Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY, et al. MiR–503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res. 2014;29(2):338–47.
28.Ji M-l, Zhang X-j, Shi P-l, Lu J, Wang S-z, Chang Q, et al. Downregulation of microRNA–193a–3p is involved in invertebral disc degeneration by targeting MMP14. J Mol Med. 2016;94(4):457–68.
29.Li H-r, Cui Q, Dong Z-y, Zhang J-h, Li H-q, Zhao L. Downregulation of miR–27b is involved in loss of type II collagen by directly targeting matrix metalloproteinase 13 (MMP13) in human intervertebral disc degeneration. Spine. 2016;41(3):E116-E23.
30.Yokoyama K, Hiyama A, Arai F, Nukaga T, Sakai D, Mochida J. C-Fos regulation by the MAPK and PKC pathways in intervertebral disc cells. PLoS ONE. 2013;8(9):e73210.
31.Wagner EF, Nebreda ÁR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537.
32.Daniels J, Binch AA, Le Maitre CL. Inhibiting IL‐1 signaling pathways to inhibit catabolic processes in disc degeneration. J Orthop Res. 2017;35(1):74–85.
33.Ulrich JA, Liebenberg EC, Thuillier DU, Lotz JC. ISSLS prize winner: repeated disc injury causes persistent inflammation. Spine. 2007;32(25):2812–9.
34.Tolonen J, Grönblad M, Virri J, Seitsalo S, Rytömaa T, Karaharju E. Oncoprotein c-Fos and c-Jun immunopositive cells and cell clusters in herniated intervertebral disc tissue. Eur Spine J. 2002;11(5):452–8.